Investors, founders, innovators and established companies facing growth equity investments meet challenges and opportunities across all sectors and stages of development. Goodwin’s industry-leading Growth Equity Practice provides innovative, insightful guidance across the private equity, technology, healthcare and life sciences sectors, and covers the full spectrum of investments. From investing in emerging growth companies to large, highly structured, leveraged transactions in established, profitable enterprises, our growth equity lawyers have a practical and commercial approach to driving successful transactions. Our growth equity practice draws from the best of our market-leading middle market buyout and venture capital practices to structure transactions that result in long term and effective partnerships between investors, entrepreneurs and management teams and frequently involve liquidity for existing owners.
As one of the most active law firms in the United States structuring high profile, complex growth equity investments, our experience extends beyond the United States to Europe, China and India. Our team is deeply experienced in transactions involving pass-throughs, leveraged recapitalizations and late stage liquidity events such as primaries, direct secondaries, private tender offers. Although our experience spans many industries, our deep roster of technology, private equity, and life sciences industry company and venture capital clients helps fuel our engagements and sourcing of growth equity opportunities.